Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06376721
Status:
RECRUITING
Last Update Posted:
2024-04-19
First Post:
2024-04-15
Brief Title:
Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or RelapsedRefractory NKT-cell Lymphoma
Sponsor:
Beijing Tongren Hospital
Organization:
Beijing Tongren Hospital
Organization Data
Organization:
Beijing Tongren Hospital
Class:
OTHER
Study ID:
TREC2024-KY016
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beijing Tongren Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
LIANG WANG
Responsible Party Title:
Director of the department of hematology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Beijing Tongren Hospital
Old Name:
None
Old Organization:
None